Skip to main content

Table 1 Baseline characteristics of the study participants

From: Combined effect of adiposity and elevated inflammation on incident type 2 diabetes: a prospective cohort study

 

Total (n = 82,172)

HsCRP < 2 mg/L (n = 60,846)

HsCRP ≥ 2 mg/L (n = 21,326)

P-difference

Age, mean (SD), years

50.4 ± 12.0

49.4 ± 11.8

53.2 ± 12.2

 < 0.0001

Male, No. (%)

66,047 (80.4)

49,241 (80.9)

16,806 (78.8)

 < 0.0001

BMI, mean (SD), kg/m2

25.0 ± 3.4

24.7 ± 3.3

25.6 ± 3.7

 < 0.0001

BMI-categories, No. (%)

   

 < 0.0001

  Underweight/normal weight

33,220 (40.4)

25,937 (42.6)

7283 (34.1)

 

  Overweight

34,273 (41.7)

25,283 (41.6)

8990 (42.2)

 

  Obese

14,679 (17.9)

9626 (15.8)

5053 (23.7)

 

Waist circumference, mean (SD), cm

86.6 ± 9.7

85.6 ± 9.4

89.3 ± 10.1

 < 0.0001

Waist circumference-categories, No. (%)

   

 < 0.0001

  Non abdominal obesity

48,935 (59.6)

38,859 (63.9)

10,076 (47.3)

 

  Abdominal obesity

33,237 (40.4)

21,987 (36.1)

11,250 (52.8)

 

Fatty liver degrees, No. (%)

   

 < 0.0001

  No fatty liver

57,611 (70.1)

44,386 (73.0)

13,225 (62.0)

 

  Gentle fatty liver

16,548 (20.1)

11,378 (18.7)

5170 (24.2)

 

  Moderate and severe fatty liver

8013 (9.8)

5082 (8.3)

2931 (13.7)

 

hsCRP, median (IQR), mg/L

0.8 (0.3–2.1)

0.5 (0.2–0.9)

4.5 (2.8–7.8)

 < 0.0001

SBP, mean (SD), mm Hg

129.7 ± 20.4

128.7 ± 20.0

132.4 ± 21.5

 < 0.0001

DBP, median (IQR), mm Hg

80.0 (78.0–90.0)

80.0 (76.7–90.0)

80.7 (79.3–90.0)

 < 0.0001

HDL-C, median (IQR), mmol/L

1.50 (1.28–1.76)

1.51 (1.28–1.77)

1.49 (1.27–1.75)

0.1001

TC, mean (SD), mmol/L

4.9 ± 1.1

4.9 ± 1.1

4.9 ± 1.1

0.0024

TG, median (IQR), mmol/L

1.25 (0.88–1.88)

1.22 (0.87–1.83)

1.31(0.92–2.00)

 < 0.0001

Family history of diabetes, No. (%)

6823 (8.3)

5230 (8.6)

1593 (7.5)

 < 0.0001

Education, No. (%)

   

 < 0.0001

  Less than high school

64,993 (79.1)

47,916 (78.8)

17,077 (80.1)

 

  High school and above

17,179 (20.9)

12,930 (21.2)

4249 (19.9)

 

Current drinker, No. (%)

31,327 (38.1)

24,134 (39.7)

7193 (33.7)

 < 0.0001

Smoking habits, No. (%)

   

 < 0.0001

  Never smoker

49,046 (59.7)

37,210 (61.2)

11,836 (55.6)

 

  Ever smoker

4457 (5.4)

3170 (5.2)

1287 (6.0)

 

  Current smoker

28,669 (34.9)

20,466 (33.6)

8203 (38.4)

 

Physical activities, No. (%)

   

 < 0.0001

  Low

7433 (9.0)

5687 (9.4)

1746 (8.2)

 

  Moderate

62,122 (75.6)

45,794 (75.2)

16,328 (76.5)

 

  High

12,617 (15.4)

9365 (15.4)

3252 (15.3)

 

CVD, No. (%)

2458 (3.0)

1588 (2.6)

870 (4.1)

 < 0.0001

Medication use, No. (%)

    

  Antihypertensives

2238 (2.7)

1426 (2.3)

812 (3.8)

 < 0.0001

  Statin

175 (0.2)

117 (0.2)

58 (0.3)

 < 0.0001

  Fibrate

64 (0.08)

38 (0.06)

26 (0.12)

0.0299

  1. BMI body mass index, CVD cardiovascular diseases, HDL-C high-density lipoprotein cholesterol, hsCRP high-sensitivity C-reactive protein, SBP systolic blood pressure TC total cholesterol, TG triglyceride